BARDA Broad Agency Announcement (medical countermeasures, incl. manufacturing platforms)
BARDA Broad Agency Announcement (medical countermeasures, incl. manufacturing platforms) is a funding call from HHS ASPR – Biomedical Advanced Research and Development Authority (BARDA) that has no fixed deadline (rolling). Funding: not stated in source data — see the official call. Eligibility: Companies and teams developing medical countermeasures (CBRN, pandemic influenza, emerging infectious disease). Three stages: pre-submission call (recommended), Quad Chart + Market Research Abstract, then invited proposal.
- Funder
- HHS ASPR – Biomedical Advanced Research and Development Authority (BARDA)
- Deadline
- Areas of interest listed; no closing date on the page – check the funder page
- Amount
- Not stated in source data — see call
- Region / eligibility
- United States
- Career stage
- industry / SME
- Fields
- pharma process
- Reference
- —
- Official call
- Funder page (curated calendar) listing
Eligibility in plain language
Companies and teams developing medical countermeasures (CBRN, pandemic influenza, emerging infectious disease). Three stages: pre-submission call (recommended), Quad Chart + Market Research Abstract, then invited proposal.
Who should apply
Medicinal chemists and pharma process / drug-development teams — best fit for companies and SMEs.
Summary from source
BARDA funds advanced R&D on medical countermeasures, including areas such as flexible vaccine manufacturing platforms and novel MCM delivery mechanisms.